The Business of Trust: Pharma & Life Sciences Third-Party Risk 

How Life Sciences Leaders Are Redefining Third-Party Risk to Accelerate Innovation, Protect Patients, and Strengthen Supply Chains

Pharmaceutical and life sciences organizations increasingly depend on complex ecosystems of contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), active pharmaceutical ingredient (API) suppliers, clinical laboratories, logistics providers, technology vendors, and other third parties to drive innovation and bring therapies to market. 

Managing risk across these interconnected relationships requires greater visibility into dynamic threats, regulatory requirements, supply chain dependencies, and operational complexity. 

This eBook explores how pharmaceutical and life sciences leaders are modernizing third-party risk management (TPRM) with continuous risk intelligence, contextualized AI, unified governance, and human expertise to identify emerging risks earlier, strengthen regulatory compliance, and make more transparent and defensible decisions across their extended ecosystems.

Use it to 

• Understand why point-in-time third-party risk approaches can no longer keep pace with dynamic life sciences ecosystems 
• Learn how Enterprise Context helps transform AI into trusted, actionable risk intelligence 
• Explore how Continuous Risk Intelligence can identify emerging third- and Nth-party risks between assessments 
• Strengthen regulatory agility and resilience across FDA, EMA, GxP, privacy, and compliance requirements 
• See how AI can scale human expertise while keeping critical risk decisions transparent and accountable 

Who It’s For 

• Third-party risk, supplier risk, and enterprise risk leaders 
• Quality, regulatory, compliance, procurement, and supply chain teams 
• Life sciences executives evaluating AI-enabled approaches to TPRM 
• Pharmaceutical, biotechnology, and medical device organizations modernizing third-party governance 

Download The Business of Trust: Pharma & Life Sciences Third-Party Risk eBook to learn how pharmaceutical and life sciences organizations can build a more resilient, intelligence-driven approach to third-party risk.